• Out-of-Stock
  • Save €0.86
search

VIT C VITA * OS 10FL 10ML 1G

  • SANOFI SpA
  • 007780075
Features:


Indicated in case of vitamin C deficiency.


Indicated in case of increased need.


Deductible over-the-counter drug.


Contributes to the proper functioning of the immune system.


















info_outline View product sheet
Final Price €6.79
Regular Price €7.65
Save €0.86
error Out-of-Stock

Notify me when available

  Convenient and safe payments

Even with a credit card

  Shipping in 48h-72h all over the world

FREE in Italy over € 39.90

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service

Drugs Others products at unbeatable price

VIT C VITA * OS 10FL 10ML 1G

Therapeutic indications

Deficiency states of VITAMIN C.

Dosage and method of use

As an indication, the dosage is as follows: Vials for oral use. Adult: 2 vials per day. Children over 2 years of age: 1 vial per day, unless otherwise prescribed. Effervescent tablets, to be dissolved in water. Adult: effervescent tablets of 1 g: ½ - 2 per day. Children over 2 years of age: half dose unless otherwise prescribed.

Contraindications

Hypersensitivity to the active substance or to any of the excipients. This medicine should not be given to children under 2 years of age.

Side effects

Hypersensitivity reactions may occur in predisposed individuals. There have been reports of headache, diarrhea and gastrointestinal upset with the intake of high doses. Reporting of suspected adverse reactions. Reporting of suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit / risk ratio of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: http://www.agenziafarmaco.gov.it/content/come-segnalare-una-sospetta-reazione-avversa.

Special warnings

Vitamin C should be used with caution by individuals who suffer or have suffered in the past from oxalate-induced nephrolithiasis and those with G6Pd deficiency, thalassemia and sideroblastic anemia, iron metabolism disorder (e.g. hemosiderosis, hemochromatosis), hyperoxalaemia ( the latter can be found after taking high doses of ascorbic acid). Vitamin C can interfere with the blood glucose test while not affecting blood sugar. It is therefore advisable for diabetic patients to stop taking the product a few days before proceeding with the glucose dosage in the urine. Additionally, ascorbic acid intake should be discontinued prior to performing the fecal occult blood test. VITAMIN C VITA in effervescent tablets, contains sucrose: each effervescent tablet contains 1.6 g. When taken at the recommended doses they provide a daily amount of 3.2 g. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency, should not take this medicine VITAMIN C VITA effervescent tablets contains 273 mg of sodium per dose (in the form of bicarbonate), equivalent to 14% of the maximum daily intake recommended by the WHO, which is 2 g of sodium for an adult. VITAMIN C VITA vials contain 719 mg of sodium (in the form of bicarbonate and metabisulfite), equivalent to approximately 36% of the maximum daily intake recommended by the WHO, which corresponds to 2 g of sodium for an adult. Furthermore, the sodium metabisulphite contained in the VITAMIN C VITA vials can rarely cause severe hypersensitivity reactions and bronchospasm. The medicine is not contraindicated for people with celiac disease.

Pregnancy and breastfeeding

Pregnancy: Vitamin C Vita passes the placental barrier. When doses of Vitamin C Vita above the therapeutic range are taken during pregnancy, paradoxical symptoms of avitaminosis have been observed in some newborns. Lactation: Ascorbic acid is excreted in breast milk.

Expiration and retention

Store at a temperature below 25 ° C.

Interactions with other drugs

The concomitant use of vitamin C with estrogen, fluphenazine, warfarin, deferoxamine is not recommended. Concomitant use of a deferoxamine dosage greater than 500 mg may cause impaired cardiac function.

Overdose

There are no known episodes of ascorbic acid overdose. Administration of very large quantities may occasionally cause mild gastrointestinal disturbances, consisting mainly of laxative phenomena. In such cases it is advisable to interrupt the treatment (cf. 4.3). Hemolytic anemia, oxalate nephrolithiasis and renal failure may occur very rarely.

Active principles

One vial of 1 g oral solution contains: active principle: ascorbic acid 1 g. Excipients with known effects: sulphite, sodium. One effervescent tablet of 1 g contains: active principle : ascorbic acid 1 g. Excipients with known effects: sucrose, sodium. For the full list of excipients, see section 6.1.

Excipients

Oral solution: sodium metabisulfite, sodium bicarbonate, purified water. Effervescent tablets: sucrose, sodium bicarbonate, tartaric acid, orange flavor, lemon flavor.

SANOFI SpA
007780075